Consider Eurofins DiscoverX’s custom development capabilities for custom cell lines, assays, & enzyme development
Receptor tyrosine kinases (RTKs) play important roles in a variety of cellular processes, including growth, motility, differentiation, and metabolism. Recent large-scale genomic studies have revealed the presence of various alterations in the genes encoding RTKs, such as EGFR, HER2/ErbB2, and MET, among many others. Dysregulation of RTK signaling leads to an assortment of human diseases, most notably numerous cancers. Abnormal RTK activation in human cancers is mediated by four principal mechanisms: gain-of-function mutations, genomic amplification, chromosomal rearrangements, and/or autocrine activation.
Eurofins DiscoverX® offers PathHunter® cell-based assays for RTK and cytokine receptors associated with cytosolic tyrosine kinases (CTK). These innovative assays provide cellular context to the activation of these receptors, as well as for the identification of novel inhibitors and therapeutic antibodies. Utilize the PathHunter assays to analyze RTK and cytokine receptor functional activity by analyzing their dimerization, phosphorylation, internalization, and SH2-recruitment.
Consider Eurofins DiscoverX’s custom development capabilities for custom cell lines, assays, & enzyme development
Eurofins DiscoverX offers a variety of cell-based assays in the form of cell lines and ready-to-use kits for functional activity, dimerization, SH2 recruitment, characterization, and screening of RTKs and CTKs associated with cytokine receptors.